Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 2d ago.
| Ticker | Firm | Action | Rating | Target | Date |
|---|---|---|---|---|---|
| EFXEquifax Inc. | Argus Research | Upgraded from Hold | Buy | — | 3d ago |
| REGNRegeneron Pharmaceuticals, Inc. | Argus Research | Upgraded from Hold | Buy | $850 | Oct 1 |
Showing the 2 most recent actions.